Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (39)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Liao, A.W.
Right arrow Articles by Nicolaides, K.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, A.W.
Right arrow Articles by Nicolaides, K.H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 7, 1501-1504, July 2001
© 2001 European Society of Human Reproduction and Embryology

First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction

A.W. Liao1, V. Heath1, N. Kametas1, K. Spencer2 and K.H. Nicolaides1,3

1 Harris Birthright Research Centre for Fetal Medicine, King's College Hospital Medical School, London and 2 Endocrine Unit, Clinical Biochemistry Department, Harold Wood Hospital, Romford, Essex, UK

BACKGROUND: The possible effect of assisted reproduction on first-trimester screening for trisomy 21 was examined by fetal nuchal translucency thickness (NT), maternal serum free ß-human chorionic gonadotrophin (HCG) and pregnancy-associated plasma protein-A (PAPP-A). METHODS: Parameters were measured at 11–14 weeks in 411 singleton pregnancies achieved by controlled ovarian stimulation, including 220 that had undergone IVF. Results were compared with 1233 singleton pregnancies conceived spontaneously. RESULTS: In the IVF pregnancies, the median fetal NT was not significantly different from that in controls, whilst the median free ß-HCG was significantly increased, and PAPP-A was significantly decreased. In the intracytoplasmic sperm injection group, fetal NT and free ß-HCG values were not significantly different from those in controls, but PAPP-A was significantly decreased. In those pregnancies achieved by ovarian stimulation, neither fetal NT, free ß-HCG nor PAPP-A were significantly different from the control group. CONCLUSIONS: In IVF pregnancies, screening for trisomy 21 by fetal NT, maternal serum free ß-HCG and PAPP-A levels may be associated with a 1.2% higher false-positive rate than in natural conception.

Key words: free ß-HCG/nuchal translucency/PAPP-A/screening/trisomy 21

3 To whom correspondence should be addressed at: Harris Birthright Research Centre for Fetal Medicine, King's College Hospital Medical School Denmark Hill, London SE5 9RS, UK. E-mail: kypros{at}fetalmedicine.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
D.J. Amor, J.X. Xu, J.L. Halliday, I. Francis, D.L. Healy, S. Breheny, H.W.G. Baker, and A.M. Jaques
Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome
Hum. Reprod., June 1, 2009; 24(6): 1330 - 1338.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.C. Gjerris, A. Loft, A. Pinborg, M. Christiansen, and A. Tabor
The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology
Hum. Reprod., January 1, 2009; 24(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.C. Gjerris, A. Loft, A. Pinborg, M. Christiansen, and A. Tabor
Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: a national cohort study
Hum. Reprod., July 1, 2008; 23(7): 1545 - 1552.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
B. Weisz and C. H. Rodeck
An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies
Hum. Reprod. Update, September 1, 2006; 12(5): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. D. Pan, I. Peter, G. M. Lambert-Messerlian, J. A. Canick, D. W. Bianchi, and K. L. Johnson
Cell-free fetal DNA levels in pregnancies conceived by IVF
Hum. Reprod., November 1, 2005; 20(11): 3152 - 3156.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
B. Horsthemke and M. Ludwig
Assisted reproduction: the epigenetic perspective
Hum. Reprod. Update, September 1, 2005; 11(5): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Bellver, C. Lara, S. R. Soares, A. Ramirez, A. Pellicer, J. Remohi, and V. Serra
First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction
Hum. Reprod., September 1, 2005; 20(9): 2623 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Maymon and A. Shulman
Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons
Hum. Reprod., April 1, 2002; 17(4): 1081 - 1085.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.